Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
Learn More
Invitrogen™ CHRND Polyclonal Antibody
Rabbit Polyclonal Antibody
Supplier: Invitrogen™ PA546828
Description
Peptide sequence: LTLGLLAALA VCGSWGLNEE ERLIRHLFQE KGYNKELRPV AHKEESVDVA Sequence homology: Cow: 91%; Dog: 100%; Guinea Pig: 93%; Human: 100%; Pig: 100%; Rabbit: 86%; Rat: 85%; Zebrafish: 78%.
The acetylcholine receptor of muscle has 5 subunits of 4 different types: 2 alpha and 1 each of beta, gamma and delta subunits. After acetylcholine binding, the receptor undergoes an extensive conformation change that affects all subunits and leads to opening of an ion-conducting channel across the plasma membrane.
Specifications
CHRND | |
Polyclonal | |
Unconjugated | |
CHRND | |
acetylcholine receptor; acetylcholine receptor delta subunit; acetylcholine receptor subunit delta; acetylcholine receptor, nicotinic, delta (muscle); AChR delta subunit; Achr-4; ACHRD; Acrd; cholinergic receptor; cholinergic receptor nicotinic delta subunit; cholinergic receptor, nicotinic delta; cholinergic receptor, nicotinic, delta (muscle); cholinergic receptor, nicotinic, delta polypeptide; CHRND; CMS2A; CMS3A; CMS3B; CMS3C; delta subunit of muscle acetylcholine receptor; FCCMS; L10076; nicotinic acetylcholine receptor delta polypeptide; SCCMS; sofa potato; sop; wu:fa01e01; zgc:110469 | |
Rabbit | |
Affinity chromatography | |
RUO | |
1144 | |
-20°C, Avoid Freeze/Thaw Cycles | |
Liquid |
Immunohistochemistry, Western Blot | |
0.5 mg/mL | |
PBS with 2% sucrose and 0.09% sodium azide | |
Q07001 | |
CHRND | |
Synthetic peptide directed towards the N-terminal of human CHRND (aa 6-55). | |
100 μL | |
Primary | |
Human | |
Antibody | |
IgG |
Safety and Handling
WARNING: Cancer - www.P65Warnings.ca.gov
Product Content Correction
Your input is important to us. Please complete this form to provide feedback related to the content on this product.
Product Title
Spot an opportunity for improvement?Share a Content Correction